Allergan Inc. (AGN) News Nov 18, 2014, 6:39 p.m.
Post# of 250665
Posted On: 11/18/2014 9:34:57 PM
Allergan Inc. (AGN) News Nov 18, 2014, 6:39 p.m.
MarketWatch News on AGN
La-Z-Boy shares rally after earnings beat targets 4:41 p.m. Today - Sue Chang
Actavis shares outpace buyout target’s gains 12:30 p.m. Today - Russ Britt
S&P 500 registers 42nd record close in skittish market 4:59 p.m. Nov. 17, 2014 - Carla Mozee
Urban Outfitters slides after earnings miss expectations 4:43 p.m. Nov. 17, 2014 - Sue Chang
Valeant says it won’t meet Actavis’s offer 12:18 p.m. Nov. 17, 2014 - Russ Britt
If you're looking big pharma, look no further than Actavis 11:33 a.m. Nov. 17, 2014 - The Trading Deck
Newscast: It's Merger Mania Monday 9:57 a.m. Nov. 17, 2014 - MarketWatch
Actavis to buy Allergan in $66 billion deal 9:35 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Actavis confirms to buy Allergan in $66 billion deal 9:30 a.m. Nov. 17, 2014 - Ciara Linnane
Mon., Nov. 17: Pfizer Stock After Pre-Market Drop 9:24 a.m. Nov. 17, 2014 - MarketWatch
Actavis, Allergan close to a deal 8:33 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Allergan's stock jumps 4.2% premarket after report of potential merger deal 8:22 a.m. Nov. 17, 2014 - Tomi Kilgore
Allergan near a buyout deal worth up to 65 billion 4:30 a.m. Nov. 17, 2014 - MarketWatch
Allergan, Actavis near cash-and-stock deal: WSJ 1:48 p.m. Nov. 16, 2014 - Andria Cheng
Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
Aegon profit hit by mortality changes 2:14 a.m. Nov. 13, 2014 - MarketWatch.com
Drug companies Salix, Intercept reeling after earnings, drama 12:15 p.m. Nov. 7, 2014 - Russ Britt
Ackman urges Allergan to open sale process, negotiate 10:33 a.m. Nov. 7, 2014 - Chelsey Dulaney
Bill Ackman scores critical win in Valeant-Allergan takeover war 4:23 p.m. Nov. 4, 2014 - Russ Britt
Regeneron skids on shortfall in Eylea sales 11:15 a.m. Nov. 4, 2014 - Russ Britt
Loading more headlines...
Advertisement
Other News on AGN
Jim Cramer's 'Mad Money' Recap: Why Running With the Bulls Is Profitable but Dangerous 8:10 p.m. Today - TheStreet.com
Goldman Hits Mother Lode on Deals 7:27 p.m. Today - The Wall Street Journal Interactive Edition
Ackman Drops Push for Allergan Meeting 6:19 p.m. Today - The Wall Street Journal Interactive Edition
Jack Lew, Irish Hero 6:15 p.m. Today - The Wall Street Journal Interactive Edition
Roche's (RHHBY) Avastin Label Expansion Approved by FDA - Analyst Blog 4:45 p.m. Today - Zacks.com
Novartis Presents Data on Heart Failure Candidate LCZ696 - Analyst Blog 4:44 p.m. Today - Zacks.com
Stock Market Today: Oil Slump Fuels S&P 500 to Fresh Record High 4:09 p.m. Today - TheStreet.com
Actavis-Allergan Deal Friendly to Shareholders 2:58 p.m. Today - Barrons.com
Stock Market Today: S&P 500 Notches New High as Oil Prices Slip and Slide 2:23 p.m. Today - TheStreet.com
Zoetis 2015 Guidance Misses As Buyout Theories Abound 2:15 p.m. Today - Investors Business Daily
Stock Movers: Why 4 Big Drug Stocks Are Rising Today 1:38 p.m. Today - Investors Business Daily
Actavis Strikes $66 Billion Deal for Botox Maker Allergan - Analyst Blog 1:20 p.m. Today - Zacks.com
Bill Ackman Says He Supports The Allergan-Actavis Deal And CEO Brent Saunders 1:17 p.m. Today - benzinga.com
Pharma ETFs in Focus on Allergan Takeover Deal - ETF News And Commentary 1:00 p.m. Today - Zacks.com
Ackman Pledges Support For Actavis Bid On Allergan 12:10 p.m. Today - benzinga.com
AstraZeneca Bets Long Term on Cancer Drugs 10:53 a.m. Today - The Wall Street Journal Interactive Edition
Stock Market News for November 18, 2014 - Market News 10:10 a.m. Today - Zacks.com
Is Bill Ackman Back? 9:56 a.m. Today - benzinga.com
Citi Raises Price Target On Actavis 7:44 a.m. Today - benzinga.com
Should Investors View the U.S. Market as a Safe Zone? 5:35 a.m. Today - InvestorPlace.com
Loading more headlines...
Press Releases on AGN
Lifshitz & Miller Law Firm Announces Investigation of Allergan, Inc., Baker Hughes Incorporated, ChyronHego Corp., Horizon Lines, Inc., Susquehanna Bancshares, Inc., Swift Energy Company and Valley Financial Corporation 3:48 p.m. Today - PR Newswire - PRF
Cosmetic Implants Market (Source: Polymers, Metals, Ceramics and Biologicals; Application: Breast, Dental, Facial and Others) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2014 - 2020 1:43 p.m. Today - PR Newswire - PRF
Fitch: Allergan Purchase by Actavis Would Pressure Ratings 1:44 p.m. Nov. 17, 2014 - BusinessWire - BZX
Fitch Affirms Actavis at 'BBB-' on Allergan Acquisition Announcement; Outlook Stable 12:20 p.m. Nov. 17, 2014 - BusinessWire - BZX
ALLERGAN SHAREHOLDER ALERT:Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Actavis 11:16 a.m. Nov. 17, 2014 - BusinessWire - BZX
ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:32 a.m. Nov. 17, 2014 - PR Newswire - PRF
Valeant Comments On Allergan Announcement 9:29 a.m. Nov. 17, 2014 - PR Newswire - PRF
Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue 9:15 a.m. Nov. 17, 2014 - PR Newswire - PRF
Physicians Continue to Voice Strong Support for Allergan via Open Letters to the Eye Care Community 9:00 a.m. Nov. 14, 2014 - BusinessWire - BZX
FDA Approves New Styles of Allergan’s NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants 4:50 p.m. Nov. 12, 2014 - BusinessWire - BZX
Allergan Board of Directors Announces Approval of Amendments to Company’s Bylaws 7:02 a.m. Nov. 12, 2014 - BusinessWire - BZX
New Survey Reveals What Women in the U.S. Really Want to Know About BOTOX® Cosmetic (onabotulinumtoxinA) 8:47 a.m. Nov. 11, 2014 - PR Newswire - PRF
Ad hoc: Biofrontera to take over the sales and marketing of Ameluz(R) in Spain from Allergan 3:20 a.m. Nov. 7, 2014 - Thomson Reuters ONE
New Survey Shows Nearly 60% Of Women Say They Would Rather Have A More Youthful Looking Face Than A More Youthful Looking Body(1) 4:25 p.m. Nov. 5, 2014 - PR Newswire - PRF
Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology 9:37 a.m. Nov. 5, 2014 - BusinessWire - BZX
Allergan Comments on California Federal Court Ruling in Insider Trading Lawsuit against Valeant & Pershing Square 1:56 p.m. Nov. 4, 2014 - BusinessWire - BZX
Valeant And Pershing Square May Vote At Special Meeting 1:27 p.m. Nov. 4, 2014 - PR Newswire - PRF
Quarterly Financial & Operational Results Release and Dividends - Research Reports on AFLAC, BlackRock, Allergan, Cabot and Cheniere Energy 8:40 a.m. Nov. 3, 2014 - PR Newswire - PRF
Allergan Canada Launches a 3D JUVEDERM(R) Visualization iPad App Powered by ModiFace 9:02 a.m. Oct. 29, 2014 - Marketwired
Allergan Comments on Valeant Letter 9:10 a.m. Oct. 27, 2014 - BusinessWire - BZX
Loading more headlines...
MarketWatch News on AGN
La-Z-Boy shares rally after earnings beat targets 4:41 p.m. Today - Sue Chang
Actavis shares outpace buyout target’s gains 12:30 p.m. Today - Russ Britt
S&P 500 registers 42nd record close in skittish market 4:59 p.m. Nov. 17, 2014 - Carla Mozee
Urban Outfitters slides after earnings miss expectations 4:43 p.m. Nov. 17, 2014 - Sue Chang
Valeant says it won’t meet Actavis’s offer 12:18 p.m. Nov. 17, 2014 - Russ Britt
If you're looking big pharma, look no further than Actavis 11:33 a.m. Nov. 17, 2014 - The Trading Deck
Newscast: It's Merger Mania Monday 9:57 a.m. Nov. 17, 2014 - MarketWatch
Actavis to buy Allergan in $66 billion deal 9:35 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Actavis confirms to buy Allergan in $66 billion deal 9:30 a.m. Nov. 17, 2014 - Ciara Linnane
Mon., Nov. 17: Pfizer Stock After Pre-Market Drop 9:24 a.m. Nov. 17, 2014 - MarketWatch
Actavis, Allergan close to a deal 8:33 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Allergan's stock jumps 4.2% premarket after report of potential merger deal 8:22 a.m. Nov. 17, 2014 - Tomi Kilgore
Allergan near a buyout deal worth up to 65 billion 4:30 a.m. Nov. 17, 2014 - MarketWatch
Allergan, Actavis near cash-and-stock deal: WSJ 1:48 p.m. Nov. 16, 2014 - Andria Cheng
Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
Aegon profit hit by mortality changes 2:14 a.m. Nov. 13, 2014 - MarketWatch.com
Drug companies Salix, Intercept reeling after earnings, drama 12:15 p.m. Nov. 7, 2014 - Russ Britt
Ackman urges Allergan to open sale process, negotiate 10:33 a.m. Nov. 7, 2014 - Chelsey Dulaney
Bill Ackman scores critical win in Valeant-Allergan takeover war 4:23 p.m. Nov. 4, 2014 - Russ Britt
Regeneron skids on shortfall in Eylea sales 11:15 a.m. Nov. 4, 2014 - Russ Britt
Loading more headlines...
Advertisement
Other News on AGN
Jim Cramer's 'Mad Money' Recap: Why Running With the Bulls Is Profitable but Dangerous 8:10 p.m. Today - TheStreet.com
Goldman Hits Mother Lode on Deals 7:27 p.m. Today - The Wall Street Journal Interactive Edition
Ackman Drops Push for Allergan Meeting 6:19 p.m. Today - The Wall Street Journal Interactive Edition
Jack Lew, Irish Hero 6:15 p.m. Today - The Wall Street Journal Interactive Edition
Roche's (RHHBY) Avastin Label Expansion Approved by FDA - Analyst Blog 4:45 p.m. Today - Zacks.com
Novartis Presents Data on Heart Failure Candidate LCZ696 - Analyst Blog 4:44 p.m. Today - Zacks.com
Stock Market Today: Oil Slump Fuels S&P 500 to Fresh Record High 4:09 p.m. Today - TheStreet.com
Actavis-Allergan Deal Friendly to Shareholders 2:58 p.m. Today - Barrons.com
Stock Market Today: S&P 500 Notches New High as Oil Prices Slip and Slide 2:23 p.m. Today - TheStreet.com
Zoetis 2015 Guidance Misses As Buyout Theories Abound 2:15 p.m. Today - Investors Business Daily
Stock Movers: Why 4 Big Drug Stocks Are Rising Today 1:38 p.m. Today - Investors Business Daily
Actavis Strikes $66 Billion Deal for Botox Maker Allergan - Analyst Blog 1:20 p.m. Today - Zacks.com
Bill Ackman Says He Supports The Allergan-Actavis Deal And CEO Brent Saunders 1:17 p.m. Today - benzinga.com
Pharma ETFs in Focus on Allergan Takeover Deal - ETF News And Commentary 1:00 p.m. Today - Zacks.com
Ackman Pledges Support For Actavis Bid On Allergan 12:10 p.m. Today - benzinga.com
AstraZeneca Bets Long Term on Cancer Drugs 10:53 a.m. Today - The Wall Street Journal Interactive Edition
Stock Market News for November 18, 2014 - Market News 10:10 a.m. Today - Zacks.com
Is Bill Ackman Back? 9:56 a.m. Today - benzinga.com
Citi Raises Price Target On Actavis 7:44 a.m. Today - benzinga.com
Should Investors View the U.S. Market as a Safe Zone? 5:35 a.m. Today - InvestorPlace.com
Loading more headlines...
Press Releases on AGN
Lifshitz & Miller Law Firm Announces Investigation of Allergan, Inc., Baker Hughes Incorporated, ChyronHego Corp., Horizon Lines, Inc., Susquehanna Bancshares, Inc., Swift Energy Company and Valley Financial Corporation 3:48 p.m. Today - PR Newswire - PRF
Cosmetic Implants Market (Source: Polymers, Metals, Ceramics and Biologicals; Application: Breast, Dental, Facial and Others) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2014 - 2020 1:43 p.m. Today - PR Newswire - PRF
Fitch: Allergan Purchase by Actavis Would Pressure Ratings 1:44 p.m. Nov. 17, 2014 - BusinessWire - BZX
Fitch Affirms Actavis at 'BBB-' on Allergan Acquisition Announcement; Outlook Stable 12:20 p.m. Nov. 17, 2014 - BusinessWire - BZX
ALLERGAN SHAREHOLDER ALERT:Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Actavis 11:16 a.m. Nov. 17, 2014 - BusinessWire - BZX
ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:32 a.m. Nov. 17, 2014 - PR Newswire - PRF
Valeant Comments On Allergan Announcement 9:29 a.m. Nov. 17, 2014 - PR Newswire - PRF
Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue 9:15 a.m. Nov. 17, 2014 - PR Newswire - PRF
Physicians Continue to Voice Strong Support for Allergan via Open Letters to the Eye Care Community 9:00 a.m. Nov. 14, 2014 - BusinessWire - BZX
FDA Approves New Styles of Allergan’s NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants 4:50 p.m. Nov. 12, 2014 - BusinessWire - BZX
Allergan Board of Directors Announces Approval of Amendments to Company’s Bylaws 7:02 a.m. Nov. 12, 2014 - BusinessWire - BZX
New Survey Reveals What Women in the U.S. Really Want to Know About BOTOX® Cosmetic (onabotulinumtoxinA) 8:47 a.m. Nov. 11, 2014 - PR Newswire - PRF
Ad hoc: Biofrontera to take over the sales and marketing of Ameluz(R) in Spain from Allergan 3:20 a.m. Nov. 7, 2014 - Thomson Reuters ONE
New Survey Shows Nearly 60% Of Women Say They Would Rather Have A More Youthful Looking Face Than A More Youthful Looking Body(1) 4:25 p.m. Nov. 5, 2014 - PR Newswire - PRF
Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology 9:37 a.m. Nov. 5, 2014 - BusinessWire - BZX
Allergan Comments on California Federal Court Ruling in Insider Trading Lawsuit against Valeant & Pershing Square 1:56 p.m. Nov. 4, 2014 - BusinessWire - BZX
Valeant And Pershing Square May Vote At Special Meeting 1:27 p.m. Nov. 4, 2014 - PR Newswire - PRF
Quarterly Financial & Operational Results Release and Dividends - Research Reports on AFLAC, BlackRock, Allergan, Cabot and Cheniere Energy 8:40 a.m. Nov. 3, 2014 - PR Newswire - PRF
Allergan Canada Launches a 3D JUVEDERM(R) Visualization iPad App Powered by ModiFace 9:02 a.m. Oct. 29, 2014 - Marketwired
Allergan Comments on Valeant Letter 9:10 a.m. Oct. 27, 2014 - BusinessWire - BZX
Loading more headlines...
(0)
(0)